ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Biofilm-Antagonist Ginger-Based 3D-Printable Photoresins for Complex Implant Designs Exhibiting Advanced Multifunctional Biomedical Applications.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Since the discovery of 3D-printing, it has revolutionized personalized drug delivery and implants by enabling intricate, customizable designs. However, key challenges remain, including complex design, host immune response, biofilm formation, and infection-induced inflammation at the implant site. This work offers, first-ever, unique ginger-based 3D-printable resins by chemically modifying Zingerol (Zing-OH, a ginger-based component) into photopolymerizable compositions that can print high-resolution complex designs via DLP 3D-printing. Briefly, the Zing-OH is amended via different functional group backbones, resulting in Zing-OH-based resins (ether, ester, and urethane) and their respective prints. Moreover, the Zing-OH prints' thermal, mechanical, and biodegradation properties can be fine-tuned by simply customizing the backbone. Furthermore, the shape memory efficacy and the human bone (nasal cartilage, vestibular, cortical, femur, etc.) mimicking mechanical properties (exhibiting 2-200 MPa compressive strength) makes them more enticing. In tandem, the prints are also hemocompatible as well as cyto-friendly against human skin (HaCaT) and lung (BEAS-2B) cells, and mouse fibroblast (NIH-3T3) cells. Concurrently, an in vivo biocompatibility study in a rat model indicates that the printed materials are biocompatible, showing no signs of severe inflammatory response over a 28-day period. More importantly, the outstanding anti-biofilm and antioxidant efficacies of the Zing-OH prints make them more appealing due to their potential to prevent implant rejection, thus making them promising tools for bone-tissue engineering (BTE) applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.